Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinblastine + Nilotinib in Pediatric Low-Grade Glioma
NCT01887522Phase 2Terminated
- Sponsor
- Gustave Roussy
- Start
- Jul 2016
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of nilotinib in glioma, sponsored by Gustave Roussy. Started Jul 2016; status: terminated.
02
Drugs
nilotinib
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01887522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01887522.